| Literature DB >> 32421977 |
Ajaikumar B Kunnumakkara1, Bano Shabnam1, Sosmitha Girisa1, Choudhary Harsha2, Kishore Banik1, Th Babita Devi2, Ruplekha Choudhury2, Henamayee Sahu2, Dey Parama2, Bethsebie L Sailo1, Krishan Kumar Thakur1, Subhash C Gupta3, Bharat B Aggarwal4.
Abstract
Most chronic diseases, caused by lifestyle factors, appear to be linked to inflammation. Inflammation is activated mechanistically, and nuclear factor-κB (NF-κB) is a significant mediator. NF-κB, one of the most studied transcription factors, was first identified in the nucleus of B lymphocytes almost three decades ago. This protein has a key function in regulating the human immune system, and its dysregulation has been linked to many chronic diseases including asthma, cancer, diabetes, rheumatoid arthritis, inflammation, and neurological disorders. Physiologically, many cytokines have been discovered that activate NF-κB. Pathologically, environmental carcinogens such as cigarette smoke, radiation, bacteria, and viruses can also activate this transcription factor. NF-κB activation controls expression of more than 500 genes, and most are deleterious to the human body when dysregulated. More than 70,000 articles have been published regarding NF-κB. This review emphasizes the upside and downside of NF-κB in normal and disease conditions and the ways in which we can control this critical transcription factor in patients.Entities:
Mesh:
Substances:
Year: 2020 PMID: 32421977 DOI: 10.1615/CritRevImmunol.2020033210
Source DB: PubMed Journal: Crit Rev Immunol ISSN: 1040-8401 Impact factor: 2.214